Matches in Wikidata for { <http://www.wikidata.org/entity/Q61918239> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q61918239 description "assaig clínic" @default.
- Q61918239 description "clinical trial" @default.
- Q61918239 description "clinical trial" @default.
- Q61918239 description "clinical trial" @default.
- Q61918239 description "clinical trial" @default.
- Q61918239 description "ensaio clínico" @default.
- Q61918239 description "ensayo clínico" @default.
- Q61918239 description "ensayu clínicu" @default.
- Q61918239 description "essai clinique" @default.
- Q61918239 description "klinisch onderzoek" @default.
- Q61918239 description "клінічне випробування" @default.
- Q61918239 description "临床试验" @default.
- Q61918239 name "Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome" @default.
- Q61918239 type Item @default.
- Q61918239 label "Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome" @default.
- Q61918239 prefLabel "Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome" @default.
- Q61918239 P1050 Q61918239-5006AEC3-01A5-4773-ABF9-66B8668D18FA @default.
- Q61918239 P1132 Q61918239-518C86DC-6497-4F55-93B6-31BB849A7470 @default.
- Q61918239 P1476 Q61918239-016ADEFC-DA66-4052-A4CC-64B4667047A4 @default.
- Q61918239 P17 Q61918239-A0663476-F67C-4C0F-8077-F37C0FECFEBA @default.
- Q61918239 P3098 Q61918239-4947153E-3A75-4214-8DD3-9E04D0D6834D @default.
- Q61918239 P31 Q61918239-1F005FCC-C820-4BCD-96B4-E0802396129F @default.
- Q61918239 P4844 Q61918239-0BC0C379-9B16-4C01-BEFC-A08686C85815 @default.
- Q61918239 P4844 Q61918239-778C123C-CBBB-41D5-ABE0-8F16183EB8EA @default.
- Q61918239 P580 Q61918239-9E06FC1F-DC7A-4963-A3A0-E78A600C937D @default.
- Q61918239 P582 Q61918239-940C2500-EAE6-4733-8041-B4513AA0C20B @default.
- Q61918239 P6099 Q61918239-EC7A03B4-07BC-4A99-A806-3506DF67EEBA @default.
- Q61918239 P6153 Q61918239-1AD569BA-1647-47E5-AFF8-EEA71978F27C @default.
- Q61918239 P6153 Q61918239-1BAB57BD-DC74-4855-BC3D-F90BBFB498C2 @default.
- Q61918239 P6153 Q61918239-860BDA00-25FC-4DF8-8349-F3AD0E6EB994 @default.
- Q61918239 P6153 Q61918239-BF4E8302-1CBF-4462-803D-122B8AB825C8 @default.
- Q61918239 P6153 Q61918239-E7833C9D-BF46-49AF-9B97-D1CF477CABF5 @default.
- Q61918239 P8005 Q61918239-35F0AFFD-FC13-436B-BCEF-68E8554A1D32 @default.
- Q61918239 P8363 Q61918239-EB69837B-E92E-48EB-A7E3-1FDE7F19B79C @default.
- Q61918239 P1050 Q179630 @default.
- Q61918239 P1132 "+25" @default.
- Q61918239 P1476 "SMD/ATG-CSA: Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome" @default.
- Q61918239 P17 Q29 @default.
- Q61918239 P3098 "NCT00488436" @default.
- Q61918239 P31 Q30612 @default.
- Q61918239 P4844 Q367700 @default.
- Q61918239 P4844 Q5199020 @default.
- Q61918239 P580 "2002-05-01T00:00:00Z" @default.
- Q61918239 P582 "2007-06-01T00:00:00Z" @default.
- Q61918239 P6099 Q42825046 @default.
- Q61918239 P6153 Q11682611 @default.
- Q61918239 P6153 Q17137104 @default.
- Q61918239 P6153 Q3297837 @default.
- Q61918239 P6153 Q50562360 @default.
- Q61918239 P6153 Q5902584 @default.
- Q61918239 P8005 Q76651189 @default.
- Q61918239 P8363 Q78089383 @default.